The trends in psoriasis drug prescription, such as delayed adoption of advanced therapies and cost-driven choices, pose challenges. However, targeted research methods allow market players to effectively address these challenges and optimize market opportunities. These methods assist in tailoring strategies for specific market segments, refining pricing strategies, engaging healthcare providers, advancing product development, and enhancing patient support. This data-driven approach empowers psoriasis drug manufacturers to respond adeptly to trends and provide more effective solutions to patients.